Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
06-26 | Redburn Atlantic Initiates Arkema at Buy | MT |
05-14 | Arkema: collaboration with ProLogium in batteries | CF |
Strengths
- With a P/E ratio at 10.31 for the current year and 9.05 for next year, earnings multiples are highly attractive compared with competitors.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 6.5B | - | ||
+0.73% | 99.64B | A- | ||
-11.98% | 58.77B | A- | ||
+75.71% | 48.81B | B | ||
+5.26% | 34.94B | B | ||
+0.61% | 31.15B | A- | ||
+3.47% | 18.62B | B- | ||
+17.33% | 17.44B | C+ | ||
+5.92% | 13.51B | B- | ||
-6.67% | 12.73B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AKE Stock
- 0IB0 Stock
- Ratings Arkema